Literature DB >> 20051944

Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.

Hung-Da Tung1, Jing-Houng Wang, Po-Lin Tseng, Chao-Hung Hung, Kwong-Ming Kee, Chien-Hung Chen, Kuo-Chin Chang, Chuan-Mo Lee, Chi-Sin Changchien, Yao-Der Chen, Sheng-Nan Lu.   

Abstract

OBJECTIVES: Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are well-known risk factors for hepatocellular carcinoma, and diabetes mellitus (DM) and overweight have also been reported as risk factors for hepatocellular carcinoma (HCC). We tried to elucidate the roles of DM and overweight in HCC development in a dual HBV and HCV endemic area of southern Taiwan.
METHODS: In 2004, a community-based comprehensive screening program was conducted in Tainan County. Hepatitis B surface antigen (HBsAg), anti-HCV, alpha-fetoprotein, complete blood counts, triglyceride, cholesterol, and glucose levels were examined. DM was defined as fasting blood sugar >126 mg per 100 ml, and overweight was defined as a body mass index >24 kg m(-2). Subjects with thrombocytopenia (platelet count <150 x 10(9) l(-1)) and elevated alpha-fetoprotein (>20 ng ml(-1)) underwent ultrasonographic screening for HCC. A total of 56,307 adults (>40 years old) participated, and 72 new HCC cases were detected and confirmed.
RESULTS: In comparisons of all 72 HCC cases with the other 144 individual age-, sex-, residency-, HBsAg-, and anti-HCV-matched controls, only thrombocytopenia and high alanine transaminase (ALT) levels were shown to be independent risk factors. Neither DM nor overweight was shown to be significant in any of the analyses.
CONCLUSIONS: On the basis of the community-based cross-sectional and case-controlled studies, neither DM nor overweight was a risk factor for HCC in a dual HBV and HCV endemic area. However, male gender, age (> or =65 years), HBsAg, anti-HCV, thrombocytopenia, and high ALT levels were independent risk factors for HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20051944     DOI: 10.1038/ajg.2009.711

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  15 in total

1.  Review.

Authors:  Hans L Tillmann
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-06

2.  A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.

Authors:  Masato Fujii; Yuichiro Shibazaki; Kyoko Wakamatsu; Yutaka Honda; Yusuke Kawauchi; Kenji Suzuki; Somasundaram Arumugam; Kenichi Watanabe; Takafumi Ichida; Hitoshi Asakura; Hiroyuki Yoneyama
Journal:  Med Mol Morphol       Date:  2013-02-22       Impact factor: 2.309

3.  Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis.

Authors:  Chun Gao; Hong-Chuan Zhao; Jing-Tao Li; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

Review 4.  Modern approach to hepatocellular carcinoma.

Authors:  Morris Sherman
Journal:  Curr Gastroenterol Rep       Date:  2011-02

5.  Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Hirokazu Takahashi; Toshihiko Mizuta; Yuichiro Eguchi; Yasunori Kawaguchi; Takuya Kuwashiro; Satoshi Oeda; Hiroshi Isoda; Noriko Oza; Shinji Iwane; Kenichi Izumi; Keizou Anzai; Iwata Ozaki; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2011-02-18       Impact factor: 7.527

6.  Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.

Authors:  Ju Dong Yang; Hager Amed Mohamed; Jessica L Cvinar; Gregory J Gores; Lewis R Roberts; W Ray Kim
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

7.  Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care.

Authors:  Yuan-Hung Kuo; Pao-Fei Chen; Jing-Houng Wang; Kuo-Chin Chang; Kwong-Ming Kee; Ming-Chao Tsai; Chun-Yin Lin; Sheng-Che Lin; Lin-San Tsai; Shu-Chuan Chen; Sheng-Nan Lu
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

8.  Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area.

Authors:  Ze Zheng; Chao Zhang; Jianhua Yan; Yanping Ruan; Xiaoyi Zhao; Xingting San; Yilei Mao; Qinghua Sun; Kezhong Zhang; Zhongjie Fan
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

9.  Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.

Authors:  Yuan-Hung Kuo; Ming-Chao Tsai; Kwong-Ming Kee; Kuo-Chin Chang; Jing-Houng Wang; Chun-Yin Lin; Sheng-Che Lin; Sheng-Nan Lu
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

10.  Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study.

Authors:  Huixian Han; Han Deng; Tao Han; Haitao Zhao; Feifei Hou; Xingshun Qi
Journal:  Med Sci Monit       Date:  2017-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.